Abstract

The caselet explains the effect of the World Trade Organization’s TRIPs (Trade-Related aspects of Intellectual Property Rights) agreement on the Indian pharma industry. It also explains why foreign pharma companies are showing keen interest in the liberalization of the Indian pharma sector.

Learning Objectives

The case is structured to achieve the following Learning Objectives:

• Effect of TRIPs agreement on the Indian pharma sector
• Liberalization of the Indian pharma industry
• and Stumbling blocks for the Indian pharma industry.

Keywords

Indian Patents Act 1970, reverse engineering, WTO, TRIPs (Trade-Related aspects of Intellectual Property Rights), exclusive marketing rights (EMR), Indian Patent Office, Cipla, FDA (Food and Drug Administration)